• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur J Pediatr . Fever without source as the first manifestation of SARS-CoV-2 infection in infants less than 90 days old

tetano

Editor, Senior Moderator
Eur J Pediatr


. 2021 Feb 19.
doi: 10.1007/s00431-021-03973-9. Online ahead of print.
Fever without source as the first manifestation of SARS-CoV-2 infection in infants less than 90 days old


Daniel Bl?zquez-Gamero[SUP] 1 2 [/SUP], Cristina Epalza[SUP] 3 4 [/SUP], Jos? Antonio Alonso Cadenas[SUP] 5 [/SUP], Lourdes Calleja Gero[SUP] 5 [/SUP], Cristina Calvo[SUP] 4 6 [/SUP], Paula Rodr?guez-Molino[SUP] 6 [/SUP], Mar?a M?ndez[SUP] 7 [/SUP], Maria Del Mar Santos[SUP] 4 8 [/SUP], Victoria Fumad?[SUP] 9 [/SUP], Mar?a Fernanda Guzm?n[SUP] 10 [/SUP], Antoni Soriano-Arandes[SUP] 4 11 [/SUP], Ana B Jim?nez[SUP] 12 [/SUP], Maria Penin[SUP] 13 [/SUP], Elvira Cobo-Vazquez[SUP] 14 [/SUP], Marta Pareja[SUP] 15 [/SUP], Zulema Lobato[SUP] 16 [/SUP], Miquel Serna[SUP] 4 17 [/SUP], Rafael Delgado[SUP] 18 [/SUP], Cinta Moraleda[SUP] #[/SUP][SUP] 3 4 17 [/SUP], Alfredo Tagarro[SUP] #[/SUP][SUP] 4 17 19 [/SUP]



Affiliations

Abstract

Fever without source (FWS) in infants is a frequent cause of consultation at the emergency department, and the emergence of SARS-CoV-2 could affect the approach to those infants. The aim of this study is to define the clinical characteristics and rates of bacterial coinfections of infants < 90 days with FWS as the first manifestation of SARS-CoV-2 infection. This is a cross-sectional study of infants under 90 days of age with FWS and positive SARS-CoV2 PCR in nasopharyngeal swab/aspirate, attended at the emergency departments of 49 Spanish hospitals (EPICO-AEP cohort) from March 1 to June 26, 2020. Three hundred and thirty-three children with COVID-19 were included in EPICO-AEP. A total of 67/336 (20%) were infants less than 90 days old, and 27/67(40%) presented with FWS. Blood cultures were performed in 24/27(89%) and were negative in all but one (4%) who presented a Streptococcus mitis bacteremia. Urine culture was performed in 26/27(97%) children and was negative in all, except in two (7%) patients. Lumbar puncture was performed in 6/27(22%) cases, with no growth of bacteria. Two children had bacterial coinfections: 1 had UTI and bacteremia, and 1 had UTI. C-reactive was protein over 20 mg/L in two children (one with bacterial coinfection), and procalcitonin was normal in all. One child was admitted to the pediatric intensive care unit because of apnea episodes. No patients died.Conclusion: FWS was frequent in infants under 90 days of age with SARS-CoV-2 infection. Standardized markers to rule out bacterial infections remain useful in this population, and the outcome is generally good. What is Known: • Fever without source (FWS) in infants is a common cause of consultation at the emergency department, and young infants have a higher risk of serious bacterial infections (SBI). • The emergence of the new coronavirus SARS-CoV-2 could affect the approach to young infants with FWS in the emergency department. management of those children is a challenge because information about bacterial coinfection and prognosis is scarce. What is New: • SARS-CoV-2 infection should be ruled out in young infants (< 90 days of age) with FWS in areas with community transmission. • Bacterial coinfection rarely coexists in those infants. • Inflammatory markers were not increased in children without bacterial coinfection. • Outcome is good in most patients.

Keywords: COVID-19; Coronavirus; Fever without source; Infant; SARS-CoV2; Serious bacterial infections.
 
Back
Top Bottom